Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 2,294	$ 2,951
Accounts receivable, net of allowances of $129 in 2022 and $122 in 2021	2,471	2,629
Inventories	2,548	2,453
Prepaid expenses and other current assets	860	839
Total current assets	8,173	8,872
Property, plant and equipment, net	5,114	5,178
Goodwill	9,816	9,836
Other intangible assets, net	7,693	7,792
Operating lease right-of-use assets	609	630
Other non-current assets	1,311	1,213
Total assets	32,716	33,521
Current liabilities:
Short-term debt	200	301
Current maturities of long-term debt and finance lease obligations	209	210
Accounts payable	1,223	1,246
Accrued expenses and other current liabilities	2,258	2,479
Total current liabilities	3,890	4,236
Long-term debt and finance lease obligations, less current portion	16,765	17,149
Operating lease liabilities	508	522
Other non-current liabilities	2,434	2,493
Total liabilities	23,597	24,400
Commitments and contingencies
Equity:
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021	683	683
Common stock in treasury, at cost,180,058,105 shares in 2022 and 181,879,516 shares in 2021	(11,422)	(11,488)
Additional contributed capital	6,207	6,197
Retained earnings	16,994	17,065
Accumulated other comprehensive (loss) income	(3,387)	(3,380)
Total Baxter stockholders’ equity	9,075	9,077
Noncontrolling interests	44	44
Total equity	9,119	9,121
Total liabilities and equity	$ 32,716	$ 33,521